Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

FAM9C Inhibitors

Inhibitors of FAM9C operate through various biochemical mechanisms to decrease its functional activity. By targeting the ATP binding sites of kinases, certain inhibitors can prevent the phosphorylation events that are crucial for the activity of FAM9C, leading to its functional inhibition. Other inhibitors specifically halt cell cycle progression by targeting cyclin-dependent kinases, which could reduce the expression levels of FAM9C during critical phases such as the G1-S transition. Histone deacetylase inhibitors contribute to this process by altering chromatin structure, thereby indirectly reducing the transcription of genes, including that of FAM9C. Further down the cell signaling pathways, the intervention into the PI3K/AKT and the MAPK/ERK pathways by respective pathway inhibitors can decrease the stability or expression of FAM9C, assuming its involvement in these pathways. This is facilitated by alteration of the phosphorylation status of downstream proteins and by affecting cell cycle regulators, which in turn, impacts the levels and function of FAM9C. In addition to interference with signaling cascades, some inhibitors disrupt intracellular protein transport mechanisms, potentially affecting the proper processing and trafficking of FAM9C. Disruption of the proteostasis network, through the inhibition of proteasome activity, may also lead to an accumulation of ubiquitinated proteins, thereby affecting the degradation pathway of FAM9C if it is a target for ubiquitination. Inhibition of molecular chaperones like HSP90 can impair the folding of a range of client proteins, among which FAM9C might be affected, leading to reduced stability and activity. The inhibition of kinases within specific families can also alter the phosphorylation status of proteins within signaling pathways that involve FAM9C, indirectly influencing its activity. Lastly, by disturbing calcium homeostasis through the inhibition of calcium ATPases, cellular processes dependent on calcium signaling can be indirectly inhibited, which may impinge upon the functional activity of FAM9C if it is reliant on such signaling mechanisms.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

A potent kinase inhibitor that blocks ATP binding sites, leading to inhibition of phosphorylation events that FAM9C may be involved in.

Palbociclib

571190-30-2sc-507366
50 mg
$315.00
(0)

A selective CDK4/6 inhibitor that halts cell cycle progression, potentially reducing the expression levels of FAM9C during the G1-S transition.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

A histone deacetylase inhibitor that alters chromatin structure, indirectly reducing the transcription of genes like FAM9C.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A PI3K inhibitor that by inhibiting the PI3K/AKT pathway may decrease the stability or expression of FAM9C, which could be implicated in this pathway.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

An MEK inhibitor that disrupts the MAPK/ERK pathway, potentially affecting proteins like FAM9C that are downstream in this pathway.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

An mTOR inhibitor that can alter the phosphorylation status of proteins involved in the mTOR signaling pathway, which may include FAM9C.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$30.00
$52.00
$122.00
$367.00
25
(3)

An inhibitor of protein transport from the endoplasmic reticulum to the Golgi apparatus, likely affecting the processing and trafficking of FAM9C.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

An MEK inhibitor that disrupts the MAPK pathway, potentially altering the phosphorylation status and function of FAM9C.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

A proteasome inhibitor that can lead to the accumulation of ubiquitinated proteins, potentially affecting the degradation of FAM9C if it is ubiquitinated.

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$38.00
$58.00
$102.00
$202.00
8
(1)

An HSP90 inhibitor that can disrupt protein folding, potentially affecting the stability and function of client proteins such as FAM9C.